[DOI] [PubMed] [Google Scholar] 74.Batista A.F., Forny-Germano L., Clarke J.R., Lyra e Silva N.M., Brito-Moreira J., Boehnke S.E., Winterborn A., Coe B.C., Lablans A., Vital J.F., et al
many clinicians start the next weekly agent about 1 week after the last dose of the prior weekly incretin, then titrate cautiously
doi: 10.1046/j.1523-1755.1999.00721.x 70 ZhouDLiuY
Reduced tissue compressibility and airway collapsibility result in fewer interruptions in breathing, highlighting the weight loss impact on sleep breathing as a critical factor in improving sleep quality and sleep apnea treatment
However, other options exist: Medicare patients: Check if your Part D plan covers Zepbound, or explore Lilly's Patient Assistance Program No insurance: Consider LillyDirect ($299-$449/month for self-pay vials) State Restrictions Savings card benefits may be limited in certain states: Massachusetts: Card not valid if an AB-rated generic equivalent is available California: Card not valid if an FDA-approved therapeutic equivalent is available Currently, there is no generic equivalent for Zepbound (tirzepatide), so these restrictions don't apply
